NEW YORK (GenomeWeb) – Genomic data firm PierianDx today announced it is exclusively licensing a proprietary genetic testing tool and processes from Washington University in St. Louis.

PierianDx will offer the tool, called the Clinical Genomicist Workstation, to other clinical labs "giving them an end-to-end solution for managing clinical next-generation sequencing processes." CGW is a software platform for NGS clinical tests that manages data and workflow, the St. Louis-based company said on its website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.